Speaker illustration

Doctor Jean-Claude Tardif

Montreal Heart Institute, Montreal (Canada)

Member of:

European Society of Cardiology

Jean-Claude Tardif CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS Jean-Claude Tardif is the Director of the Research Centre at the Montreal Heart Institute and Professor of Medicine at the University of Montreal. Dr Tardif graduated from the University of Montreal with his medical degree in 1987 and completed his training in cardiology and research in Montreal and Boston in 1994. Dr Tardif holds the Canada Research Chair in personalized medicine and the University of Montreal endowed research chair in atherosclerosis. He is the Scientific Director of the Montreal Health Innovations Coordinating Centre (MHICC). His research covers the molecular and genomic aspects of atherosclerosis and related diseases and also involves animal models, mechanistic and observational clinical studies as well as early clinical studies and large international randomized trials. He was inducted in the Order of Canada (the highest distinction in the country).

Ask the Trialists from Hot Line 1

Event: ESC Congress 2023

Topic: European Society of Cardiology

Session type: Ask the Trialists


Late Breaking Trials - COVID-19

Event: ESC Congress 2021 - The Digital Experience

Topic: Other

Session type: Late-Breaking Science


Meet the trialist - COMMANDER HF - Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session type: Late-Breaking Science


Going further in treatment of angina with ivabradine

Event: ESC Congress 2016

Topic: Angina pectoris stable

Session type: Satellite Symposium


ESC 365 is supported by